A fluorescent reporter of ATP binding-competent receptor kinases
Graphical abstract
Section snippets
Acknowledgments
This work was supported by a grant from the American Cancer Society (98-277-07, J.N.W.) the NIH/NCI (CA98881-05, R.L.) the Women’s Cancer League Developmental Grant (R.L.), and the Braman Family Breast Cancer Institute (R.L.). J.N.W. is grateful to the National Science Foundation for providing funds towards the purchase of an LC-ESI-MS (CHE-0946858).
References and notes (27)
- et al.
Structure
(2008) - et al.
Cell Signalling
(2006) - et al.
J. Photochem. Photobiol. A Chem.
(1996) - et al.
Cell
(2002) - et al.
Cancer Treat. Rev.
(2009) - et al.
J. Med. Chem.
(1995) - et al.
J. Clin. Oncol.
(2008) - et al.
Drugs
(2000) - et al.
J. Clin. Invest.
(2008) - et al.
Proc. Natl. Acad. Sci. U.S.A.
(1993)
Nat. Cell Biol.
Science
Chem. Rev.
Cited by (8)
Discovery of EGFR-Targeted Environment-Sensitive fluorescent probes for cell imaging and efficient tumor detection
2022, Bioorganic ChemistryCitation Excerpt :Significant progress in EGFR visualization continues to be made, and is generally based on the following strategies: genetically encoded fluorescent biosensors [8], and EGF or cetuximab antibodies conjugated with fluorescent tags to bind to the EGFR extracellular domain [9–12]. In addition to the extracellular ligand macromolecules, fluorescent ligands for intracellular ATP-binding pockets derived from clinical kinase inhibitors have also been developed, and are particularly useful owing to their reversible response to biotargets and their high-throughput capability in new drug discovery and screening [13–16]. Introducing an environment-sensitive fluorophore into the drug ligand, is a possible strategy to design this type of receptor-targeting fluorescent probe with a switching mechanism, which has little impact on the affinity of the parental drug.
Synthesis and photophysical properties of a fluorescent cyanoquinoline probe for profiling ERBB2 kinase inhibitor response
2017, Bioorganic and Medicinal ChemistryCitation Excerpt :Genomic analysis can provide great predictive power for the efficacy of certain drugs, but functional phenotypic assays are also a useful tool. To this end, we recently reported fluorescent kinase probes, kProbes, directed at the EGFR/ERBB family of receptor tyrosine kinases.4–6 Modification of an N-phenyl quinazoline core, an established ERBB-targeted pharmacophore common to erlotinib, gefitinib and lapatinib,7,8 introduced environmentally responsive fluorescence switching, such that the probes are non-emissive, or OFF in solution and become photoemissive upon binding, i.e. emission is switched ON.4
Binding-induced, turn-on fluorescence of the EGFR/ERBB kinase inhibitor, lapatinib
2015, Organic and Biomolecular ChemistryFluorescent kinase inhibitors as probes in cancer
2021, Chemical Society ReviewsEmission tuning of fluorescent kinase inhibitors: Conjugation length and substituent effects
2014, Journal of Organic Chemistry